Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)-Reference-Cited by-同舟云学术

Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)

Published:2019-10-23 Issue:1 Volume:18 Page:191-200
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Pasternack Ralf¹,Büchold Christian¹,Jähnig Robert¹,Pelzer Christiane¹,Sommer Michael¹,Heil Andreas¹,Florian Peter²,Nowak Götz³,Gerlach Uwe²,Hils Martin¹

Affiliation:

1. Zedira GmbH Darmstadt Germany

2. Sanofi‐Aventis Deutschland GmbH Frankfurt Germany

3. Jena University Jena Germany

Funder

Bundesministerium für Forschung und Technologie

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14646

Reference37 articles.

1. Accelerated Lysis of Blood Clots

2. Structure of Active Coagulation Factor XIII Triggered by Calcium Binding: Basis for the Design of Next-Generation Anticoagulants

3. Novel Insights into Structure and Function of Factor XIIIa-Inhibitor Tridegin

4. Factor XIII and the clotting of fibrinogen: from basic research to medicine

5. Transglutaminases: Protein Cross-Linking Enzymes in Tissues and Body Fluids

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Heparin Mimetic, Potent, and Selective Inhibitors of Human Clotting Factor XIIIa;ACS Omega;2024-07-03

2. Role of factor XIII in ischemic stroke: a key molecule promoting thrombus stabilization and resistance to lysis;Journal of Thrombosis and Haemostasis;2023-12

3. Progress of nanomaterials in the treatment of thrombus;Drug Delivery and Translational Research;2023-11-25

4. AI-Driven Advancements in Medicine and Education: A Pilot Study on AI-Assisted Diagnosis and Treatment for Blood Coagulation Disorder;2023 13th International Conference on Information Technology in Medicine and Education (ITME);2023-11-24

5. The role of coagulome in the tumor immune microenvironment;Advanced Drug Delivery Reviews;2023-09